(AP)—Pharmaceutical companies that can no longer rely on lucrative patents to drive profits are increasingly teaming up with academia in search of the next big drug discovery.
Jan 10, 2013
0
0
(AP)—Four sisters who claimed in a lawsuit their breast cancer was caused by synthetic estrogen their mother took during pregnancy in the 1950s have reached a settlement with the drug company Eli Lilly and Co.
Jan 9, 2013
0
0
(AP)—Eli Lilly and Co. said Friday its 2013 earnings will grow more than Wall Street expects, even though the drugmaker will lose U.S. patent protection for two more key products this year.
Jan 4, 2013
0
0
(HealthDay)—The financial burden of caring for patients with chronic low back pain (CLBP) in the United Kingdom is twice that of caring for patients without CLBP, according to a study published in the Jan. 1 issue of Spine.
Jan 3, 2013
0
0
(HealthDay)—For infants, supplementation of formula with long-chain polyunsaturated fatty acids (LCPUFAs) correlates with improved visual acuity in the first year of life, according to research published online Dec. 17 ...
Dec 17, 2012
0
0
Eli Lilly's experimental Alzheimer's drug has flashed potential to help with mild cases of the disease, but patients and doctors will have to wait a few more years to learn whether regulators will allow the drugmaker to sell ...
Dec 12, 2012
0
0
Antibodies against amyloid beta (Aβ) protein deposits that are thought to play a role in Alzheimer's disease have shown some success in preventing the buildup of deposits in animals, but they have not been effective at removing ...
Dec 5, 2012
0
1
(HealthDay)—Despite differences in processes of care and raw mortality for patients with severe sepsis and septic shock in the United States and Europe, after adjustment, mortality rates are similar, according to a study ...
Oct 26, 2012
1
0
(HealthDay)—In men with complete erectile dysfunction (ED), tadalafil 2.5 and 5 mg once-daily result an in intercourse success rate of 32.4 and 46.4 percent, respectively, according to research published online Oct. 4 in ...
Oct 14, 2012
0
0
Combined results from two studies of an experimental Alzheimer's drug suggest it might modestly slow mental decline, especially in patients with mild disease.
Oct 8, 2012
0
0
